M&A Deal Summary

Clinigen Group Acquires Link Healthcare Pty

On September 22, 2015, Clinigen Group acquired medical products company Link Healthcare Pty for 45M GBP

Acquisition Highlights
  • This is Clinigen Group’s 1st transaction in the Medical Products sector.
  • This is Clinigen Group’s 2nd largest (disclosed) transaction.
  • This is Clinigen Group’s 1st transaction in Australia.

M&A Deal Summary
Date 2015-09-22
Target Link Healthcare Pty
Sector Medical Products
Buyer(s) Clinigen Group
Deal Type Add-on Acquisition
Deal Value 45M GBP

Target

Link Healthcare Pty

Warriewood, Australia
website
Link Healthcare Pty Ltd. is a provider of specialist pharmaceutical products and medical devices.

Search 177,729 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Clinigen Group

Burton-on-Trent, United Kingdom

website

Category Company
Founded 2008
Sector Medical Products
Employees1,250
Revenue 504M GBP (2020)
DESCRIPTION

Clinigen Group is a specialty global pharmaceutical products company. Clinigen Group was founded in 2008 and is based in Burton-on-Trent, the United Kingdom.

DEAL STATS #
Overall 5 of 8
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 3 of 5
Country (Australia) 1 of 1
Year (2015) 3 of 3
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-29 Idis Group Holdings

Weybridge, United Kingdom

Idis Group Holdings Ltd. is a provider of managed healthcare services.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-02 Totect

United States

Totect (dexrazoxane HCI) is an emergency medicine used to reverse the toxic effects of anthracycline anti-cancer treatment. Totect® reverses this damage, allowing patients to continue their essential anti-cancer treatment.

Buy -
Mergr

Product

Company

Legal